Vertex Pharmaceuticals Incorporated Stock
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
406.2 USD | +1.57% | +2.99% | -0.23% |
03:59pm | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
Apr. 18 | Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain | MT |
Financials (USD)
Sales 2024 * | 10.72B | Sales 2025 * | 11.74B | Capitalization | 103B |
---|---|---|---|---|---|
Net income 2024 * | 3.86B | Net income 2025 * | 4.44B | EV / Sales 2024 * | 8.06 x |
Net cash position 2024 * | 16.91B | Net cash position 2025 * | 21.28B | EV / Sales 2025 * | 6.99 x |
P/E ratio 2024 * |
26.8
x | P/E ratio 2025 * |
23.4
x | Employees | 5,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.89% |
Latest transcript on Vertex Pharmaceuticals Incorporated
1 day | +1.18% | ||
1 week | +2.74% | ||
Current month | -3.12% | ||
1 month | -2.66% | ||
3 months | -7.90% | ||
6 months | +10.15% | ||
Current year | -0.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 17-01-31 | |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Charles Wagner
DFI | Director of Finance/CFO | 55 | 19-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 17-06-07 |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Bruce Sachs
BRD | Director/Board Member | 64 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 406.7 | +1.69% | 148 396 |
24-04-22 | 399.9 | +1.43% | 1,393,886 |
24-04-19 | 394.3 | +0.20% | 1,342,138 |
24-04-18 | 393.5 | +0.10% | 949,091 |
24-04-17 | 393.1 | -0.27% | 881,020 |
Delayed Quote Nasdaq, April 23, 2024 at 09:46 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.47% | 103B | |
+3.69% | 96.73B | |
+0.73% | 21.31B | |
-16.44% | 21.21B | |
-6.40% | 18.79B | |
-42.14% | 16.37B | |
-23.06% | 13.68B | |
+8.18% | 13.44B | |
+22.61% | 10.98B | |
-21.41% | 8.56B |
- Stock Market
- Equities
- VRTX Stock